Updated Jul 16, 2026
Kovelman Harry has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $32K.
Harry Kovelman serves as the Chief Medical Officer at Myomo, Inc., a company specializing in wearable medical robotics for neuromuscular disorders. His role involves overseeing the medical aspects of the company's myoelectric orthotic products.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-12 | MYO | MYOMO, INC. | F — Tax withholding / forfeiture | 10.4K | $1.20 | $13K |
| 2026-06-09 | MYO | MYOMO, INC. | F — Tax withholding / forfeiture | 7.6K | $1.33 | $10K |
| 2026-05-29 | MYO | MYOMO, INC. | S — Open-market sale | 11.5K | $1.02 | $12K |
| 2026-05-29 | MYO | MYOMO, INC. | S — Open-market sale | 20.5K | $1.00 | $21K |
| 2025-06-30 | MYO | MYOMO, INC. | F — Tax withholding / forfeiture | 13.1K | $2.19 | $29K |
| 2024-11-05 | MYO | MYOMO, INC. | F — Tax withholding / forfeiture | 121 | $3.70 | $448 |
| 2024-10-04 | MYO | MYOMO, INC. | F — Tax withholding / forfeiture | 121 | $3.86 | $467 |
Harry Kovelman serves as the Chief Medical Officer at Myomo, Inc., a company specializing in wearable medical robotics for neuromuscular disorders. His role involves overseeing the medical aspects of the company's myoelectric orthotic products.…
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($32K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kovelman Harry profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.